Three new apprenticeship schemes have been introduced in the medtech sector as part of Government attempts to plug the skills gap in the domestic manufacturing industry. Irish Medtech Association and
R & D Investment
Cambrex, manufacturer of small molecule active pharmaceutical ingredients (APIs), has announced it is investing in new capacity and continuous flow technology at its Karlskoga facility in Sweden. The investment includes
Even before European officials present the groundwork for relocating the bloc’s drug regulator, a fight has emerged between countries vying for the economic lift and status that come with hosting the
Iterum Therapeutics has raised €58M to fund Phase III and bring a new antibiotic to a market where innovation is lacking. Iterum Therapeutics is a biotech based in Dublin that
The European Medicines Agency’s (EMA) 2016 annual report focuses on the Agency’s key achievements in the areas of medicine evaluation, support to research and development of new and innovative treatments and
Ashfield Healthcare Communications, a global healthcare communications agency, announces significant growth across the UK and Europe. Ashfield Healthcare Communications has a new presence in Dublin, Ireland, joining the office of
Spain’s pharmaceutical market set to show signs of stability, surpassing $25 billion by 2021, says GlobalData. The Spanish pharmaceutical market is set to see a slight rise in value from
Pharmaceutical wholesaler United Drug has announced a €40 million investment in technology and innovation at its headquarters at Citywest in Dublin. United Drug works with more than 1,800 pharmacies, hospitals,
Inoviem Scientific, a contract research biotech (CRB), has secured funding of €750k from existing financial partners to support the company’s growth. The funding includes €650k from Cap Innov’Est, the French
On April 18, 2017 Fujifilm announced the completion of a $93-million cGMP production facility in Texas. The facility expansion is part of the company’s goal to increase the production capacity
University of Dundee in the UK has been awarded almost £1m to boost efforts to identify new new antibiotics to tackle bacterial infections. Antimicrobial resistance is one of the greatest
PureTech will take on the development of two mTORC1 inhibitors from Novartis aimed at stopping the decline of the immune system associated with age. Novartis is building up the portfolio
Global healthcare company Sanofi and therapeutic companion software company Voluntis have agreed to a collaboration to help improve decision-making and self-management for type 2 diabetics treated with basal insulin. The
Last year, Cardiff, U.K.-based Verona secured £44.7 million ($65.6 million) from big-name investors on both sides of the Atlantic for work on its PDE3/PDE4 inhibitor RPL554, and has now teamed
Medical device firm Mainstay Medical said operating expenses rose by $3.9 million for 2016 to $16.8 million as Mainstay kicked off its ReActiv-8 B clinical trial and began commercialising the
Newron, an Italian biotech focused on CNS diseases, is on a roll. The latest win? FDA approval of its Parkinson’s drug, Xadago. Just in time for World Parkinson’s Day on
Shire has secured label expansion approval from the European Commission for its hereditary angioedema therapy Cinryze. The European Commission (EC) has approved the label extension application, granting three new indications
Cerenis therapeutic’s lead candidate CER-001 has failed Phase II for the treatment of patients with post-acute coronary syndrome (ACS). The French-based Biotech Cerenis is developing therapies for the treatment ofcardiovascular and
MedImmune, the global biologics research and development arm of AstraZeneca, and Sanofi Pasteur, the vaccines division of Sanofi, have announced an agreement to develop and commercialise MEDI8897 jointly. MEDI8897 is
SenzaGen and AstraZeneca will develop a new genomic signature to distinguish allergens from irritants in the respiratory tract Swedish in vitro testing company, SenzaGen, has signed a collaboration agreement with
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing gene therapies for life-threatening rare diseases, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products has
In an editorial published in the journal ecancermedicalscience, leading academics from across the UK explore the risks facing cancer care,
A new method to help diagnose oesophageal cancer is being researched by engineers and physicians at the Institute of Biological
Diagnostics company, Owlstone Medical, who is developing a breathalyser for disease has announced it has signed a master service agreement
Researchers at the Universities of Dundee and Edinburgh in Scotland are looking to work with the pharmaceutical industry to improve
Dublin-headquartered pharma company Allergan is to invest €42 million in its Irish operations this year. The company, which employs approximately
The report, commissioned by the Association of the British Pharmaceutical Industry (ABPI) and supported by the Association of the British
Sanofi and its vaccines global business unit Sanofi Pasteur announced today an agreement with MedImmune, the global biologics research and development arm of
Price rises in the EU stir Members of European Parliament to discuss ways to make medicines more affordable, including increasing
Sheffield Teaching Hospitals NHS Foundation trust will lead a new virtual specialist surgical centre, designed to tackle complex rare urogenital
Oneview Healthcare, the Irish hospital software group, has reported strong revenue growth in its first year as a listed company.
On 1 March the newly established European Reference Networks (ERNs) has started their work. ERNs are unique and innovative cross-border
The company’s latest report states that key drivers of the Russian healthcare market include improving regulatory guidelines and government initiatives
The joint venture will combine Sanofi’s biologics development pipeline with Lonza’s expertise to design, construct, start-up and operate a state-of-the-art
Big Pharma companies Pfizer, Sanofi and Johnson & Johnson were among the big investors last year in the Flanders region of
Alnwick-based research and development company, Arc Trinova Ltd, trading as Arcinova, recently received approval for funding from the UK’s Rural
Arix Biosciences has made good on its promise to raise £100 million ($127 million) in its public offering on the
Strong product pipeline will drive double-digit growth rates in the Western Europe and US markets, finds Frost & Sullivan’s Transformational
Modus Therapeutics has raised €3.4M to support the completion of a Phase II trial for sickle cell disease, a painful condition
Biopharmaceutical, analytical and bioanalytical contract solutions provider, SGS has announced that it is expanding its elemental analysis and testing capabilities
Basel-based BioMedPartners announes the first round of BioMedInvest III, its third equity venture capital fund at CHF75m. Up to 16
Global supply partner for drugs, biologics and consumer health products, Catalent, has announced that it has completed the acquisition of
Botox maker Allergan said it would buy body-contouring product maker Zeltiq Aesthetics for about $2.48 billion (€2.34 billion), adding muscle
The Irish Government risks losing out on hundreds of millions of euro in savings on its drug bill because of
Multiple pharmaceutical companies have signed on to participate in a £14-million (approximately $17.47-million) research project focused on drug safety, according
Biotech company Nemaura Pharma has secured up to £5 million funding from private investors for the development of a hormone
A high-tech robot that helps surgeons perform highly precise and minimally-invasive surgery has been used over 1,000 times at Sheffield
The European Commission (EC) has granted marketing authorisation in Europe for Sanofi‘s Suliqua, a titratable fixed-ratio combination of basal insulin
The company announced an investment in a new facility in Dundalk, County Louth, Ireland. In November 2016, the company
The materials science institute AMBER, headquartered at Trinity College in Dublin, will continue its cooperation with Nokia Bell Labs and
Ireland’s presence in the medtech research industry has just received a massive boost as Cúram, the Centre for Research in
Advertisements
